Share Fund
To generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related securities, including equity derivatives, in the Indian markets. The Scheme will predominantly invest in large cap stocks. The Scheme could also additionally invest in Foreign Securities.
Suitability
This product is suitable for investors who are seeking
• An open-ended equity growth scheme
• Long term capital appreciation
• Investment in equity and equity related securities, including equity derivatives in the Indian markets and foreign securities; with predominant investments in large cap stocks.
| Scheme Class | Equity |
| Scheme Category | Large-Cap |
| Expense Ratio | 1.7% |
| Min subscription | ₹ 5,000 |
| Scheme Type | Open-ended |
| Scheme AUM (in Crs.) | ₹ 480 |
| AMC AUM (in Crs.) | ₹ 70,944 |
| Min Addition Subscription | ₹ 1,000 |
| Benchmark Type | S&P BSE 100 India TR INR |
| Exit Load | Exit load of 1.0%, if redeemed between (0-1) years. No Exit load, if redeemed after 1 years. |
| Fund | Min SIP Inv. | Min Inv. | Returns 3Y |
|---|---|---|---|
SBI Bluechip Fund - Direct Plan | 1000 | 1000 | 7.75% |
Aditya Birla Sun Life Frontline Equity Fund - Direct Plan | 1000 | 1000 | 6.27% |
Nippon India Large Cap Fund - Direct Plan | 1000 | 1000 | 3.91% |
SBI Bluechip Fund - Direct Plan | 1000 | 1000 | 7.75% |
Aditya Birla Sun Life Frontline Equity Fund - Direct Plan | 1000 | 1000 | 6.27% |
Mirae Asset Large Cap Fund - Direct Plan | 1000 | 1000 | 9.06% |
Mirae Asset Large Cap Fund - Direct Plan | 1000 | 1000 | 9.06% |
ICICI Prudential Bluechip Fund - Direct Plan | 100 | 100 | 7.34% |
Mirae Asset Large Cap Fund - Direct Plan | 1000 | 1000 | 9.06% |
Axis Bluechip Fund - Direct Plan | 100 | 100 | 15.23% |
ICICI Prudential Bluechip Fund - Direct Plan | 100 | 100 | 7.34% |
| Company | Holding Type | Asset(%) |
|---|---|---|
Reliance Industries Ltd | Equity | 9 |
HDFC Bank Ltd | Equity | 8 |
Bharti Airtel Ltd | Equity | 6 |
Infosys Ltd | Equity | 5 |
ICICI Bank Ltd | Equity | 5 |
Kotak Mahindra Bank Ltd | Equity | 4 |
Housing Development Finance Corp Ltd | Equity | 3 |
Divi's Laboratories Ltd | Equity | 3 |
Hindustan Unilever Ltd | Equity | 3 |
Dr Reddy's Laboratories Ltd | Equity | 3 |
| Asset | Percent |
|---|---|
Equity | 98 |
Cash - Repurchase Agreement | 2 |
Equity - Warrants Rights (Call) | 0 |
Cash | 0 |
Preferred Stock | 0 |
| Sector | Percent |
|---|---|
Financial Services | 27 |
Healthcare | 13 |
Technology | 11 |
Basic Materials | 10 |
Consumer Defensive | 10 |
Fund Manager
Venugopal Manghat
7+ years of experience
Vihang Naik
0+ years of experience
Alok Ranjan
0+ years of experience
About
investor.line@lntmf.co.in
Phone
1800 4190 200
Address
L&T Investment Management Limited,6th Floor, Mafatlal Centre,,Nariman Point, Mumbai - 400 021
